glp 1 gip 1 Science Behind and Glucagon Receptor Agonists for Obesity Research | News & Announcements The Road towards Triple Agonists:

The compound significantly reduced lesion area in ethanol-induced and stress-induced models compared to controls, establishing the gastroprotective profile that would drive subsequent research (Sikiric et al., 1993, Journal of Physiology Paris

If you have heart failure, kidney disease, or type 2 diabetes as your primary concern, an SGLT2 inhibitor may be your first-line option

Data are mean SEM from chow-fed WT (vehicle or drug treated) and Bbs5 / (vehicle or drug treated) male mice

Research published in Naunyn-Schmiedeberg Archives of Pharmacology confirmed this in isolated human atrial tissue

That's why we're putting our collective experience on the table today